[ADHD in adult patients with substance use disorders].
ADHS bei erwachsenen Patienten mit Substanzkonsumstörungen.
Addiction
Consensus
Diagnostics
Review
Treatment
Journal
Der Nervenarzt
ISSN: 1433-0407
Titre abrégé: Nervenarzt
Pays: Germany
ID NLM: 0400773
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
14
8
2019
medline:
26
9
2019
entrez:
14
8
2019
Statut:
ppublish
Résumé
Attention-deficit/hyperactivity disorder (ADHD) is a common comorbidity in adult patients with substance use disorders (SUDs). The diagnostics and treatment of ADHD with SUD are often a challenge, also with respect to the prescription of stimulants. Recently, a group of international experts developed a consensus paper on the diagnosis and treatment of comorbid ADHD and SUD. In addition, the German S3 guidelines on ADHD have been published, which also give advice on the treatment of ADHD in comorbid SUD. The German S3 guidelines on alcohol-related disorders and methamphetamine-related disorders also address ADHD as a comorbidity. Summary of consensus and guideline recommendations, supplemented with the most recent literature. In recent years new findings on the comorbidity of ADHD in patients with SUD have emerged. A series of screening and diagnostic instruments have meanwhile been evaluated in this patient group. The consensus paper and various guidelines therefore provide clinicians with specific help in detecting ADHD in patients with SUD and in conducting further diagnostics and treatment of both disorders. For example, the importance of stimulants in the treatment of patients with SUD and ADHD has significantly changed and first studies on psychotherapeutic interventions specific to this comorbidity are now available.
Sections du résumé
BACKGROUND
BACKGROUND
Attention-deficit/hyperactivity disorder (ADHD) is a common comorbidity in adult patients with substance use disorders (SUDs). The diagnostics and treatment of ADHD with SUD are often a challenge, also with respect to the prescription of stimulants. Recently, a group of international experts developed a consensus paper on the diagnosis and treatment of comorbid ADHD and SUD. In addition, the German S3 guidelines on ADHD have been published, which also give advice on the treatment of ADHD in comorbid SUD. The German S3 guidelines on alcohol-related disorders and methamphetamine-related disorders also address ADHD as a comorbidity.
METHODS
METHODS
Summary of consensus and guideline recommendations, supplemented with the most recent literature.
CONCLUSION
CONCLUSIONS
In recent years new findings on the comorbidity of ADHD in patients with SUD have emerged. A series of screening and diagnostic instruments have meanwhile been evaluated in this patient group. The consensus paper and various guidelines therefore provide clinicians with specific help in detecting ADHD in patients with SUD and in conducting further diagnostics and treatment of both disorders. For example, the importance of stimulants in the treatment of patients with SUD and ADHD has significantly changed and first studies on psychotherapeutic interventions specific to this comorbidity are now available.
Identifiants
pubmed: 31407043
doi: 10.1007/s00115-019-0779-2
pii: 10.1007/s00115-019-0779-2
doi:
Substances chimiques
Central Nervous System Stimulants
0
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
926-931Références
Exp Clin Psychopharmacol. 2002 Aug;10(3):286-94
pubmed: 12233989
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Drug Alcohol Depend. 2006 Feb 1;81(2):137-48
pubmed: 16102908
Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54
pubmed: 18403134
Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9
pubmed: 22209385
Am J Addict. 2013 May-Jun;22(3):292-6
pubmed: 23617874
JAMA Psychiatry. 2013 Jul;70(7):740-9
pubmed: 23754458
Addiction. 2014 Mar;109(3):440-9
pubmed: 24118269
Addiction. 2014 Feb;109(2):262-72
pubmed: 24118292
Drug Alcohol Depend. 2014 Jan 1;134:158-166
pubmed: 24156882
J Child Psychol Psychiatry. 2014 Aug;55(8):878-85
pubmed: 25158998
JAMA Psychiatry. 2015 Jun;72(6):593-602
pubmed: 25887096
Am J Psychiatry. 2015 Oct;172(10):967-77
pubmed: 25998281
J Clin Psychopharmacol. 2016 Jun;36(3):222-8
pubmed: 27043119
Atten Defic Hyperact Disord. 2016 Sep;8(3):159-72
pubmed: 27059489
Addiction. 2016 Oct;111(10):1867-78
pubmed: 27061514
Am J Psychiatry. 2017 Sep 1;174(9):877-885
pubmed: 28659039
J Atten Disord. 2018 Jan 1;:1087054717750272
pubmed: 29308693
Eur Addict Res. 2018;24(1):43-51
pubmed: 29510390
Eur Arch Psychiatry Clin Neurosci. 2019 Sep;269(6):667-679
pubmed: 30483874
Drug Alcohol Depend. 2019 Feb 1;195:52-58
pubmed: 30583265
Drug Alcohol Depend. 2019 Apr 1;197:28-36
pubmed: 30769263
Nervenarzt. 2019 Apr 11;:null
pubmed: 30976828